Literature DB >> 22798185

Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience.

Min Soo Cho1, Sung Hoon Kim, Seung Woo Park, Jin Hong Lim, Gi Hong Choi, Joon Seong Park, Jae Bock Chung, Kyung Sik Kim.   

Abstract

BACKGROUND: The surgical resection of hilar cholangiocarcinoma is extremely challenging because the tumor is closely related with the complicated hilar structures. We investigated to identify the outcomes for patients who underwent surgical resection and to identify the parameters that influenced radical resection.
METHODS: From January 2000 to December 2009, 105 patients underwent surgical resection for hilar cholangiocarcinoma. The clinicopathological parameters and surgical outcomes were retrospectively analyzed.
RESULTS: There were 15 operative mortalities (14.3%). Seventy-four patients underwent curative resection (70.5%). The median overall survival time for R0, R1, and R2 were 58, 28, and 19 months, respectively. Caudate lobectomy (p = 0.044; odds ratio [OR], 4.386) and perineural invasion (p = 0.01; OR, 0.062) were correlated with curative resection. Total bilirubin levels of more than 3 g/dl just before the operation (p = 0.042; hazard ratio [HR], 2.109) and extent of resection (R1 and 2 vs R0; p = 0.05; HR, 2.309) were selected as significantly negative factors affecting overall survival on the multivariate analysis.
CONCLUSIONS: Caudate lobectomy and neurectomy may be thought of as adjustable territories by the surgeon's efforts to achieve curative resection. R0 resection achieved through those efforts and liver optimization using preoperative biliary drainage may offer the patients a chance of cure.

Entities:  

Mesh:

Year:  2012        PMID: 22798185     DOI: 10.1007/s11605-012-1960-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  30 in total

1.  The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilar cholangiocellular carcinoma: a retrospective cohort study.

Authors:  Y K Hong; S B Choi; K H Lee; S W Park; Y N Park; J S Choi; W J Lee; J B Chung; K S Kim
Journal:  Eur J Surg Oncol       Date:  2011-01-11       Impact factor: 4.424

2.  Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?

Authors:  M Miyazaki; H Ito; K Nakagawa; S Ambiru; H Shimizu; Y Shimizu; A Kato; S Nakamura; H Omoto; N Nakajima; F Kimura; T Suwa
Journal:  Surgery       Date:  1998-02       Impact factor: 3.982

3.  Descriptive epidemiology of cholangiocarcinoma in Italy.

Authors:  Domenico Alvaro; Emanuele Crocetti; Stefano Ferretti; Maria Consiglia Bragazzi; Riccardo Capocaccia
Journal:  Dig Liver Dis       Date:  2009-12-22       Impact factor: 4.088

4.  Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer.

Authors:  Moon Jae Chung; Kyong Joo Lee; Seungmin Bang; Seung Woo Park; Kyung Sik Kim; Woo Jung Lee; Si Young Song; Jae Bock Chung; Jeong Youp Park
Journal:  Ann Surg Oncol       Date:  2011-01-06       Impact factor: 5.344

5.  Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor).

Authors:  Sander Dinant; Michael F Gerhards; E A J Rauws; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2006-04-14       Impact factor: 5.344

6.  Surgery for hilar cholangiocarcinoma: the Leeds experience.

Authors:  E Hidalgo; S Asthana; H Nishio; J Wyatt; G J Toogood; K R Prasad; J P A Lodge
Journal:  Eur J Surg Oncol       Date:  2007-11-26       Impact factor: 4.424

Review 7.  Hilar cholangiocarcinoma: current management.

Authors:  Fumito Ito; Clifford S Cho; Layton F Rikkers; Sharon M Weber
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

8.  The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma.

Authors:  Sander Dinant; Michael F Gerhards; Olivier R C Busch; Hugo Obertop; Dirk J Gouma; Thomas M Van Gulik
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

9.  Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience.

Authors:  Tsuyoshi Igami; Hideki Nishio; Tomoki Ebata; Yukihiro Yokoyama; Gen Sugawara; Yuji Nimura; Masato Nagino
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-10-06       Impact factor: 7.027

10.  Preoperative biliary drainage for biliary tract and ampullary carcinomas.

Authors:  Masato Nagino; Tadahiro Takada; Masaru Miyazaki; Shuichi Miyakawa; Kazuhiro Tsukada; Satoshi Kondo; Junji Furuse; Hiroya Saito; Toshio Tsuyuguchi; Tatsuya Yoshikawa; Tetsuo Ohta; Fumio Kimura; Takehiro Ohta; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16
View more
  35 in total

1.  Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.

Authors:  Xu-Feng Zhang; Eliza W Beal; Jeffery Chakedis; Qinyu Chen; Yi Lv; Cecilia G Ethun; Ahmed Salem; Sharon M Weber; Thuy Tran; George Poultsides; Andre Y Son; Ioannis Hatzaras; Linda Jin; Ryan C Fields; Stefan Buettner; Charles Scoggins; Robert C G Martin; Chelsea A Isom; Kamron Idrees; Harveshp D Mogal; Perry Shen; Shishir K Maithel; Carl R Schmidt; Timothy M Pawlik
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

Review 2.  Preoperative biliary drainage in hilar cholangiocarcinoma: When and how?

Authors:  Woo Hyun Paik; Nerenthran Loganathan; Jin-Hyeok Hwang
Journal:  World J Gastrointest Endosc       Date:  2014-03-16

Review 3.  Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.

Authors:  Irinel Popescu; Traian Dumitrascu
Journal:  Langenbecks Arch Surg       Date:  2014-05-20       Impact factor: 3.445

4.  A new clinically based staging system for perihilar cholangiocarcinoma.

Authors:  Roongruedee Chaiteerakij; William S Harmsen; Carlos Romero Marrero; Mohammed M Aboelsoud; Albert Ndzengue; Joseph Kaiya; Terry M Therneau; William Sanchez; Gregory J Gores; Lewis R Roberts
Journal:  Am J Gastroenterol       Date:  2014-11-11       Impact factor: 10.864

Review 5.  Perioperative Management of Hilar Cholangiocarcinoma.

Authors:  Katherine E Poruk; Timothy M Pawlik; Matthew J Weiss
Journal:  J Gastrointest Surg       Date:  2015-05-29       Impact factor: 3.452

6.  Prognostic significance of contrast-enhanced CT attenuation value in extrahepatic cholangiocarcinoma.

Authors:  Yoshiki Asayama; Akihiro Nishie; Kousei Ishigami; Yasuhiro Ushijima; Yukihisa Takayama; Daisuke Okamoto; Nobuhiro Fujita; Takao Ohtsuka; Tomoharu Yoshizumi; Shinichi Aishima; Yoshinao Oda; Hiroshi Honda
Journal:  Eur Radiol       Date:  2016-10-17       Impact factor: 5.315

7.  Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma.

Authors:  Hai-Jie Hu; Yan-Wen Jin; Rong-Xing Zhou; Wen-Jie Ma; Qin Yang; Jun-Ke Wang; Fei Liu; Nan-Sheng Cheng; Fu-Yu Li
Journal:  J Gastrointest Surg       Date:  2018-08-03       Impact factor: 3.452

Review 8.  Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Authors:  Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

9.  Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.

Authors:  Cecilia G Ethun; Alexandra G Lopez-Aguiar; Douglas J Anderson; Andrew B Adams; Ryan C Fields; Maria B Doyle; William C Chapman; Bradley A Krasnick; Sharon M Weber; Joshua D Mezrich; Ahmed Salem; Timothy M Pawlik; George Poultsides; Thuy B Tran; Kamran Idrees; Chelsea A Isom; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Kenneth Cardona; Shishir K Maithel
Journal:  Ann Surg       Date:  2018-05       Impact factor: 12.969

10.  Is Pancreaticoduodenectomy Feasible for Recurrent Remnant Bile Duct Cancer Following Bile Duct Segmental Resection?

Authors:  Jae Geun Lee; Sung Hwan Lee; Jin Hong Lim; Joon Seong Park; Dong Sup Yoon; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2015-09-04       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.